Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inmaculada Hernandez
Yuting Zhang

Showing results (41-50 of 1,451) with videos related to

Pageof 146
Sort By:
JAMA Oncology|May 1, 2018
Total Costs of Chimeric Antigen Receptor T-Cell ImmunotherapyInmaculada Hernandez, Vinay Prasad, Walid F Gellad
Journal of General Internal Medicine|June 5, 2020
Interpreting COVID-19 Test Results: a Bayesian ApproachChester B Good, Inmaculada Hernandez, Kenneth Smith
JAMA Health Forum|April 21, 2023
A Prescription for Achieving Equitable Access to Antiobesity MedicationsDavene R Wright, Jingchuan Guo, Inmaculada Hernandez
Annals of Internal Medicine|July 2, 2019
Statins for Primary Prevention of Cardiovascular DiseaseChester B Good, Inmaculada Hernandez, Natasha Parekh
BMC Medicine|December 19, 2018
Avoiding rash decisions about zoster vaccination: insights from cost-effectiveness evidenceChester B Good, Natasha Parekh, Inmaculada Hernandez
Health Services Research|April 17, 2022
Consequences of forgoing prescription drug subsidies among low-income Medicare beneficiaries with diabetesAlexandra Glynn, Inmaculada Hernandez, Eric T Roberts
JAMA Network Open|July 13, 2023
Contextualizing the Price of Biosimilar Adalimumab Based on Historical Rebates for the Original Formulation of Branded AdalimumabSean R Dickson, Nico Gabriel, Inmaculada Hernandez
Journal of Managed Care & Specialty Pharmacy|October 1, 2021
Emerging treatments for lupus nephritis: health equity considerations in clinical research and coverageTerri V Newman, Jingchuan Guo, Inmaculada Hernandez
JAMA Oncology|October 17, 2018
Accounting for All Costs in the Total Cost of Chimeric Antigen Receptor T-Cell Immunotherapy-ReplyInmaculada Hernandez, Vinay Prasad, Walid F Gellad
JAMA Dermatology|August 14, 2020
Trends in List and Net Prices of Self-administered Systemic Psoriasis Therapies Manufactured by US-Based Pharmaceutical CompaniesLaura K Ferris, Walid F Gellad, Inmaculada Hernandez
Pageof 146

Showing results (41-50 of 1,451) with videos related to

Sort By:
Pageof 146
JAMA Oncology|May 1, 2018
Total Costs of Chimeric Antigen Receptor T-Cell ImmunotherapyInmaculada Hernandez, Vinay Prasad, Walid F Gellad
Journal of General Internal Medicine|June 5, 2020
Interpreting COVID-19 Test Results: a Bayesian ApproachChester B Good, Inmaculada Hernandez, Kenneth Smith
JAMA Health Forum|April 21, 2023
A Prescription for Achieving Equitable Access to Antiobesity MedicationsDavene R Wright, Jingchuan Guo, Inmaculada Hernandez
Annals of Internal Medicine|July 2, 2019
Statins for Primary Prevention of Cardiovascular DiseaseChester B Good, Inmaculada Hernandez, Natasha Parekh
BMC Medicine|December 19, 2018
Avoiding rash decisions about zoster vaccination: insights from cost-effectiveness evidenceChester B Good, Natasha Parekh, Inmaculada Hernandez
Health Services Research|April 17, 2022
Consequences of forgoing prescription drug subsidies among low-income Medicare beneficiaries with diabetesAlexandra Glynn, Inmaculada Hernandez, Eric T Roberts
JAMA Network Open|July 13, 2023
Contextualizing the Price of Biosimilar Adalimumab Based on Historical Rebates for the Original Formulation of Branded AdalimumabSean R Dickson, Nico Gabriel, Inmaculada Hernandez
Journal of Managed Care & Specialty Pharmacy|October 1, 2021
Emerging treatments for lupus nephritis: health equity considerations in clinical research and coverageTerri V Newman, Jingchuan Guo, Inmaculada Hernandez
JAMA Oncology|October 17, 2018
Accounting for All Costs in the Total Cost of Chimeric Antigen Receptor T-Cell Immunotherapy-ReplyInmaculada Hernandez, Vinay Prasad, Walid F Gellad
JAMA Dermatology|August 14, 2020
Trends in List and Net Prices of Self-administered Systemic Psoriasis Therapies Manufactured by US-Based Pharmaceutical CompaniesLaura K Ferris, Walid F Gellad, Inmaculada Hernandez
Pageof 146